Arbutus Biopharma Sets Date for Q1 2024 Financial Results

Arbutus Biopharma

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced plans to unveil its first quarter financial results for 2024 on Thursday, May 2.

The biopharmaceutical company will release its earnings at 7:30 a.m. ET, followed by a conference call and webcast at 8:45 a.m. ET to discuss the findings and provide a corporate update.

Participants wishing to join the conference call should register in advance using the provided registration link. Additionally, the live webcast will be accessible through the Investors section of Arbutus’ website, with an archived version available shortly after the event concludes.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Ory Corp appoints Jeff Kukowski as CEO to Propel Growth in Identity Management